The influence of cyclosporin on graft and patient survival after renal transplantation. The Groote Schuur Hospital experience.
Fifty pretransfused patients received kidney allografts from brain-dead donors. Cyclosporin was combined with low-dose steroid administration for immunosuppression. Three months after transplantation azathioprine was substituted for the cyclosporin. Patient and graft survival rates were 94% and 88% respectively, with a mean follow-up period of 8 months (range 1-15 months). HLA A, B, C and DR antigens were not considered in the selection of recipients. The ease of use of cyclosporin and its infrequent side-effects are discussed.